Lyon Street Capital’s Allergan plc AGN Stock Holding History

Lyon Street Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	-$586K	–	65
2019 Q1	$586K	Buy	+4,000	New	+$580K	1.8%	30

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lyon Street Capital's AGN Position: Q2 2019 in Review

Lyon Street Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 4,000 shares — an estimated $586K sold.

Lyon Street Capital first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $586K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Lyon Street Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Lyon Street Capital sold 4,000 Allergan plc shares in Q2 2019, an estimated $586K.
Lyon Street Capital first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
Lyon Street Capital's Allergan plc position peaked at $586K in Q1 2019.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Lyon Street Capital's 13F filing for Q2 2019, filed 14 Aug 2019.